Poon Christine A 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2023/8/25 申報
- 申報編號
- 0001968202-23-000029
- 申報時間
- 2023/8/25
- 交易日
- 2023/8/23
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $1,031 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Poon Christine ACIK 0001189014 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/8/23 | Common Stock | M行使選擇權取得 | +12,280 | $273.67 | +$3,360,667.6 | 14,317 | 直接 | |
| 2023/8/23 | Common Stock | S賣出處分 | −300 | $837.92F1 | −$251,376 | 14,017 | 直接 | |
| 2023/8/23 | Common Stock | S賣出處分 | −1,998 | $838.60F2 | −$1,675,522.8 | 12,019 | 直接 | |
| 2023/8/23 | Common Stock | S賣出處分 | −3,032 | $839.45F3 | −$2,545,212.4 | 8,987 | 直接 | |
| 2023/8/23 | Common Stock | S賣出處分 | −6,450 | $840.65F4 | −$5,422,192.5 | 2,537 | 直接 | |
| 2023/8/23 | Common Stock | S賣出處分 | −500 | $841.05F5 | −$420,525 | 2,037 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/8/23 | Common Stock | M行使選擇權處分 | −12,280 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 300 shares of Company stock on August 23, 2023 at prices ranging from $837.83 to $837.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales 1,998 shares of Company stock on August 23, 2023 at prices ranging from $838.02 to $838.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 3,032 shares of Company stock on August 23, 2023 at prices ranging from $839.01 to $839.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 6,450 shares of Company stock on August 23, 2023 at prices ranging from $840.01 to $840.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 500 shares of Company stock on August 23, 2023 at prices ranging from $841.02 to $841.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。